Partnerships

At TriSalus, we are passionate about achieving our goal of improving outcomes for patients diagnosed with cancers of the liver or pancreas. We know that disease control with single-agent immunotherapy alone is generally short-term, and there are many patients for whom immunotherapy is ineffective. Our quest is to find optimal immunotherapy combinations to improve efficacy while limiting toxicity. Therefore, we are engaged with a range of like-minded innovators to help us improve patients’ lives. We are always open to exploring collaboration opportunities. If you are an innovator in immuno-oncology and would like to explore how we might work together, please reach out to our business development group at businessdevelopment@trisaluslifesci.com.